
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tadalafil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Recipient : Eli Lilly
Deal Size : Undisclosed
Deal Type : Acquisition
Zuellig Pharma Acquires Cialis® and Alimta® from Lilly in ASEAN Markets
Details : Through the acquisition, Zuellig will access Cialis (tadalafil) for erectile dysfunction and Alimta (pemetrexed) for pleural mesothelioma and non-small cell lung cancer from Eli Lilly.
Product Name : Cialis
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 06, 2024
Lead Product(s) : Tadalafil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Recipient : Eli Lilly
Deal Size : Undisclosed
Deal Type : Acquisition

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Quetiapine Hemifumarate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Recipient : Luye Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : Luye grants Zuellig exclusive rights to distribute Seroquel (quetiapine fumarate, immediate release) and Seroquel XR (extended release formulation), atypical anti-psychotic medicines with antidepressant properties, for schizophrenia & bipolar disorder, i...
Product Name : Seroquel
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 02, 2021
Lead Product(s) : Quetiapine Hemifumarate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Recipient : Luye Pharma
Deal Size : Undisclosed
Deal Type : Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : TAK-919
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Recipient : Moderna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Zuellig Pharma Partners with Moderna to Supply Moderna’s Covid-19 Vaccine in Asia
Details : Zuellig Pharma’s division, ZP Therapeutics will supply, mRNA-1273, the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
April 29, 2021
Lead Product(s) : TAK-919
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Moderna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement

Contact Us!